Shankar Lal Rampal Dye-Chem Limited
Shankar Lal Rampal Dye-Chem Limited (SRD) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Commodities›Chemicals›Chemicals & Petrochemicals›Trading - Chemicals
srdyechem.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-02
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 | Jun 2025 | Sept 2025 |
|---|---|---|---|
| Sales | 107 Cr | 122 Cr | 113 Cr |
| Operating expenses (approx.) | 103 Cr | 116 Cr | 109 Cr |
| EBITDA | 4 Cr | 6 Cr | 4 Cr |
| OPM % | 3.6% | 5.1% | 3.4% |
| Other income | 0 Cr | 0 Cr | 0.02 Cr |
| Interest | 0.24 Cr | 0.49 Cr | 0.19 Cr |
| Depreciation | 0.03 Cr | 0.03 Cr | 0.03 Cr |
| Profit before tax | 4 Cr | 6 Cr | 4 Cr |
| Tax % | 28.7% | 25.3% | 34.0% |
| Net profit | 3 Cr | 4 Cr | 2 Cr |
| EPS (₹) | ₹0.39 | ₹0.66 | ₹0.37 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2025 | TTM |
|---|---|---|
| Sales | 402 Cr | Sign in for TTM |
| Operating expenses (approx.) | 385 Cr | Sign in for TTM |
| EBITDA | 16 Cr | Sign in for TTM |
| OPM % | 4.1% | Sign in for TTM |
| Other income | 0.0009 Cr | Sign in for TTM |
| Interest | 0.92 Cr | Sign in for TTM |
| Depreciation | 0.10 Cr | Sign in for TTM |
| Profit before tax | 15 Cr | Sign in for TTM |
| Tax % | 26.2% | Sign in for TTM |
| Net profit | 11 Cr | Sign in for TTM |
| EPS (₹) | ₹1.78 | Sign in for TTM |
| Dividend payout % | 2.8% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 |
|---|---|
| Equity capital | 64 Cr |
| Reserves | 46 Cr |
| Borrowings | 18 Cr |
| Other liabilities | 1 Cr |
| Total liabilities | 129 Cr |
| Fixed assets (net) | 1 Cr |
| CWIP | 0 Cr |
| Investments | 0 Cr |
| Inventories | 13 Cr |
| Trade receivables | 76 Cr |
| Cash & bank | 1 Cr |
| Other assets | 38 Cr |
| Total assets | 129 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2025 |
|---|---|
| Cash from operating activity | -13 Cr |
| Cash from investing | 0.01 Cr |
| Cash from financing | 10 Cr |
| Net cash flow | -2 Cr |
| Free cash flow (OCF − Capex) | -13 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2025 |
|---|---|
| ROCE % | 12.8% |
| ROE % | 10.4% |
| Debtor days | 69 |
| Inventory days | 11 |
| Days payable | 1 |
| Cash conversion cycle | 79 |
| Debt / equity | 0.16 |
| Current ratio | 6.66 |
| Net debt / EBITDA | 1.00 |
Compare with peers
Loading peers…